Brief: Clearmind Medicine Launches First U.S. Clinical Site For Its FDA-Approved Clinical Trial To Combat Alcoholism
16/04/2025 13:41
April 16 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE LAUNCHES FIRST U.S. CLINICAL SITE FOR ITS FDA-APPROVED CLINICAL TRIAL TO COMBAT ALCOHOLISM Source text: ID:nGNX7jKKq7 Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM